MedTrace Logo

Clinicopathologic and Ancillary Testing of Primary Clear Cell Carcinoma of the Cervix

NCT05046080 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2026-02-19

No results posted yet for this study

Summary

This study aims to provide a comprehensive report on clinicopathologic features, immunohistochemical/biomarker testing and molecular profile of cervical clear cell carcinoma. This study may help researchers learn more about the molecular profile of cervical clear cell carcinoma.

Conditions

  • Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type

Interventions

OTHER

Electronic Health Record Review

Medical records reviewed

OTHER

Laboratory Biomarker Analysis

Correlative studies

Sponsors & Collaborators

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Anasis Malpica · M.D. Anderson Cancer Center

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-06
Primary Completion
2026-09-29
Completion
2026-09-29

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05046080 on ClinicalTrials.gov